The stock of Titan Medical Inc. (NASDAQ: TMDI) as of market close is around $2.02. At that price level, it has increased in value by 935.90% from its 52-week low. The intraday trading price for Titan Medical stock has been $2.45 and $1.96.
Within the past 52 weeks, TMDI stock has hit a high of $3.47 and a low of $0.19 while recent trading sessions has seen an intraday change of just 12.85%. TMDI stock rose on an analyst recommendation released on the day.
Medical device company Titan Medical Inc. has its head office in Toronto, and it develops robotic-assisted technologies for use during single-access surgery. By Titan Medical, the Enos system is being developed with dual high-definition 3D and 2D vision systems, multi-articulating instruments, and an ergonomic physician workstation.
Titan will first pursue gynecological surgical indications with the Enos system. While Titan retains worldwide commercialization rights to the Enos system and its patents, certain of Titan’s robotic-assisted surgical technologies were licensed to Medtronic plc.
Oppenheimer started tracking the TMDI stock on April 07, 2021, and has assigned the TMDI an “Outperform” rating while setting a price target of $4.00 for it.
Titan Medical announced that its President & CEO David McNally will be speaking in an event on Wednesday, April 21, 2021, at 2:00 p.m. ET. McNally, who is also Chairman of TMDI’s board, will present an overview of Titan Medical and its Enos robotic single access surgical system.
Head of Titan Medical (TMDI) head will be participating in the Bloom Burton & Co. Healthcare Investor Conference. In the Investors section on the website TMDI, shortly after the end of the live presentation, a link to the presentation will be provided.